Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2022 Earnings Call Transcript

Page 3 of 3

Jason Butler: Okay. Thank you.

Operator: Thank you. There are no further questions at this time. You may proceed.

Nancy Simonian: Thank you, operator. Thank you everyone for joining us today. We look forward to an exciting and productive year ahead and thank you for your continued support of Syros. Please reach out to us with any further questions. Have a great day.

Follow Syros Pharmaceuticals Inc.

Page 3 of 3